These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17472676)

  • 1. Hanging groin and persistent pruritus in a patient from Burkina Faso.
    Niamba P; Gaulier A; Taïeb A
    Int J Dermatol; 2007 May; 46(5):485-6. PubMed ID: 17472676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
    Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
    Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis.
    Abanobi OC; Chukwuocha UM; Onwuiiliri CO; Opara KC
    East Afr J Public Health; 2011 Mar; 8(1):33-7. PubMed ID: 22066280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
    Nikièma AS; Koala L; Sondo AK; Post RJ; Paré AB; Kafando CM; Kambiré RS; Sow B; Bougouma C; Dabiré RK; Traoré S
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009117. PubMed ID: 33647010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onchocerciasis presenting with lower extremity, hypopigmented macules.
    Vernick W; Turner SE; Burov E; Telang GH
    Cutis; 2000 May; 65(5):293-7. PubMed ID: 10826090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onchocerciasis diagnosis and the probability of visual loss in patients with skin snips negative for Onchocerca volvulus microfilariae.
    Langham ME; Richardson R
    Tropenmed Parasitol; 1981 Sep; 32(3):171-80. PubMed ID: 7345681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic image (82). A man with different leg colors. Onchocerciasis].
    Verburg GP
    Ned Tijdschr Geneeskd; 2002 Mar; 146(13):616. PubMed ID: 11957381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of forest onchocerciasis in the Lower Cross River Basin, Nigeria: change in clinical and parasitological indices after 6 years of ivermectin intervention.
    Opara KN; Fagbemi BO; Atting IA; Oyene UE; Okenu DM
    Public Health; 2007 Mar; 121(3):202-7. PubMed ID: 17241647
    [No Abstract]   [Full Text] [Related]  

  • 9. Community treatment with ivermectin for onchocerciasis in the east Usambara mountains.
    Mwetta E; Hills E
    East Afr Med J; 1994 Dec; 71(12):790-1. PubMed ID: 7705249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
    Koala L; Nikiema A; Post RJ; Paré AB; Kafando CM; Drabo F; Traoré S
    Acta Trop; 2017 Feb; 166():96-105. PubMed ID: 27845063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of Onchocerca volvulus in Sudan.
    Mukhtar MM; Khier MM; Baraka OZ; Homeida MM
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S129-31. PubMed ID: 9861278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent updates on onchocerciasis: diagnosis and treatment.
    Udall DN
    Clin Infect Dis; 2007 Jan; 44(1):53-60. PubMed ID: 17143815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A five-year-old child with a subcutaneous forehead nodule.
    Westblade LF; Fischer PU; Haghi N; Schniederjan MJ; Pritt BS; Long JG; Jerris RC; Garola RE
    Pediatr Dev Pathol; 2015; 18(2):164-6. PubMed ID: 25569144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Onchocerciasis].
    Enk CD; Gardlo K; Ruzicka T; BenEzra D
    Hautarzt; 2003 Jun; 54(6):513-7. PubMed ID: 12759735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin.
    Adewale B; Oyerinde JP; Mafe MA
    West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onchocerciasis--river blindness.
    Enk CD
    Clin Dermatol; 2006; 24(3):176-80. PubMed ID: 16714198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south-eastern Nigeria.
    Anosike JC; Dozie IN; Ameh GI; Ukaga CN; Nwoke BE; Nzechukwu CT; Udujih OS; Nwosu DC
    Ann Trop Med Parasitol; 2007 Oct; 101(7):593-600. PubMed ID: 17877878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin does not reduce the burden of itching in an onchocerciasis endemic community.
    Whitworth JA; Luty AJ; Maude GH; Morgan D; Downham MD; Taylor DW
    Trans R Soc Trop Med Hyg; 1992; 86(3):281-3. PubMed ID: 1412653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based treatment of onchocerciasis with ivermectin in southwest Nigeria: dermatological response to a singledose therapy.
    Osungbade KO; Asuzu MC; Kale OO
    Afr J Med Med Sci; 2001 Dec; 30(4):352-5. PubMed ID: 14510119
    [No Abstract]   [Full Text] [Related]  

  • 20. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.
    Ogbuagu KF; Eneanya CI
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S139-45. PubMed ID: 9861280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.